UW Center for Mendelian Genomics
威斯康星大学孟德尔基因组学中心
基本信息
- 批准号:8393219
- 负责人:
- 金额:$ 490.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-12-05 至 2015-11-30
- 项目状态:已结题
- 来源:
- 关键词:AffectBiologicalCandidate Disease GeneChromosome MappingClinicalCodeCollaborationsCommunitiesComplexCouplingDNADNA SequenceDataDatabasesDepositionDevelopmentDiagnosisDiseaseEmployee StrikesEnsureEquilibriumExhibitsFamilyFunctional disorderGene MutationGenesGeneticGenomeGenomicsGoalsHereditary DiseaseHuman BiologyHuman GenomeHuman Genome ProjectIndividualInheritance PatternsInvestigationLeadershipLinkMedical GeneticsMethodsMolecularOnline SystemsOpen Reading FramesPathway AnalysisProcessProductionProtocols documentationRare DiseasesReportingResearchResearch DesignResearch PersonnelResourcesRoleSamplingSequence AnalysisTechnologyUniversitiesVariantWashingtonWorkanalytical methodbasebiobankcostdata sharingdatabase of Genotypes and Phenotypesdisease-causing mutationexomeexome sequencinggenetic linkage analysisgenome analysisgenome sequencinggenome-widehuman diseaseimprovedinnovationinsightnew technologynext generationpositional cloningprogramspublic health relevancerepositorysuccess
项目摘要
DESCRIPTION (provided by applicant): Over the past three decades, the genes underlying nearly 3,000 Mendelian disorders have been identified by methods such as linkage analysis and positional cloning. Although the availability of a reference human genome greatly accelerated these efforts, there are thousands of additional suspected Mendelian disorders that remain unsolved. An understanding of the genetic basis of a Mendelian disorder can yield fundamental insights into basic human biology and disease pathophysiology, as well as a molecular basis for diagnosis or carrier status determination. In some instances, biological insights from studying Mendelian disorders can prove highly relevant to our understanding of more common diseases. Recently, we and others have shown that the coupling of targeted capture and next-generation DNA sequencing technology can be used to cost-effectively determine nearly all coding variation in an individual human genome, a process termed exome sequencing. We, and others, have also demonstrated how exome sequencing can be applied to efficiently identify the causal genes for Mendelian disorders that have proven intractable to conventional modes of analysis. To accelerate progress towards a comprehensive understanding of the genetic basis of all Mendelian disorders, we propose to establish the UW Center for Mendelian Genomics. Our proposal has four specific aims: (1) To organize samples for all unsolved Mendelian disorders from investigators around the world, either by their submission to our center for sequencing, or by their inclusion on a public sample list that we will develop; (2) To apply our existing production pipeline for exome and genome sequencing to samples corresponding to unsolved Mendelian disorders, and to improve this process through ongoing technology innovation; (3) To determine the genetic basis for as many unsolved Mendelian disorders as possible, through efficient study design and effective, innovative analysis; (4) To take a leadership role in the dissemination of methods and data.
描述(由申请人提供):在过去的三十年中,通过连锁分析和位置克隆等方法已经鉴定了近 3,000 种孟德尔疾病的基因。尽管参考人类基因组的出现极大地加速了这些努力,但还有数千种疑似孟德尔疾病仍未得到解决。了解孟德尔疾病的遗传基础可以产生对基本人类生物学和疾病病理生理学的基本见解,以及诊断或携带者状态确定的分子基础。在某些情况下,研究孟德尔疾病的生物学见解可能与我们对更常见疾病的理解高度相关。最近,我们和其他人已经证明,靶向捕获和下一代 DNA 测序技术的结合可用于经济高效地确定单个人类基因组中的几乎所有编码变异,这一过程称为外显子组测序。我们和其他人还证明了如何应用外显子组测序来有效识别孟德尔疾病的致病基因,这些疾病已被证明难以用传统的分析模式解决。为了加速全面了解所有孟德尔疾病的遗传基础,我们建议建立威斯康星大学孟德尔基因组学中心。我们的提案有四个具体目标:(1)组织来自世界各地研究人员的所有未解决的孟德尔疾病的样本,要么将它们提交给我们的中心进行测序,要么将它们纳入我们将开发的公共样本列表中; (2)将我们现有的外显子组和基因组测序生产流程应用于未解决的孟德尔疾病对应的样本,并通过持续的技术创新改进这一流程; (3) 通过高效的研究设计和有效、创新的分析,确定尽可能多的未解决的孟德尔疾病的遗传基础; (4) 在方法和数据传播方面发挥领导作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL Joseph BAMSHAD其他文献
MICHAEL Joseph BAMSHAD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL Joseph BAMSHAD', 18)}}的其他基金
University of Washington Mendelian Genomics Research Center (UW-MGRC)
华盛顿大学孟德尔基因组学研究中心 (UW-MGRC)
- 批准号:
10215884 - 财政年份:2021
- 资助金额:
$ 490.04万 - 项目类别:
University of Washington Mendelian Genomics Research Center (UW-MGRC)
华盛顿大学孟德尔基因组学研究中心 (UW-MGRC)
- 批准号:
10415070 - 财政年份:2021
- 资助金额:
$ 490.04万 - 项目类别:
University of Washington Mendelian Genomics Research Center (UW-MGRC)
华盛顿大学孟德尔基因组学研究中心 (UW-MGRC)
- 批准号:
10612917 - 财政年份:2021
- 资助金额:
$ 490.04万 - 项目类别:
Genetic and Molecular Basis of Congenital Contractures
先天性挛缩的遗传和分子基础
- 批准号:
7982492 - 财政年份:2010
- 资助金额:
$ 490.04万 - 项目类别:
相似国自然基金
气候梯度下云南典型草地土壤微生物群落调控碳利用效率机制的研究
- 批准号:32301439
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
膝关节软骨退变多模态磁共振成像与软骨及滑膜相关生物标记物表达关系的实验研究
- 批准号:82360339
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
基于ERRα介导线粒体生物能的芪参颗粒治疗肿瘤心脏病的分子机制与效应成分研究
- 批准号:82374420
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
生物质/含氮废弃物可控热裂解-定向催化重整过程调控与多还原组分分解炉脱硝机制研究
- 批准号:52372024
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
农用地膜抗氧化剂的土壤污染特征及其微生物效应与机制研究
- 批准号:42377223
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Male x Female Protein Interactions Mediating Reproductive Success in the Drosophila Mating Plug
雄性与雌性蛋白质相互作用介导果蝇交配插头的繁殖成功
- 批准号:
10824541 - 财政年份:2024
- 资助金额:
$ 490.04万 - 项目类别:
Alternatively spliced cell surface proteins as drivers of leukemogenesis and targets for immunotherapy
选择性剪接的细胞表面蛋白作为白血病发生的驱动因素和免疫治疗的靶点
- 批准号:
10648346 - 财政年份:2023
- 资助金额:
$ 490.04万 - 项目类别:
Preclinical Development of a Novel Therapeutic Agent for Idiopathic Pulmonary Fibrosis
特发性肺纤维化新型治疗剂的临床前开发
- 批准号:
10696538 - 财政年份:2023
- 资助金额:
$ 490.04万 - 项目类别:
Project 3: Therapeutic Gene Editing for Huntington's Disease
项目3:亨廷顿病的治疗性基因编辑
- 批准号:
10668769 - 财政年份:2023
- 资助金额:
$ 490.04万 - 项目类别: